These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability. Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639 [TBL] [Abstract][Full Text] [Related]
87. Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma. Shia J Semin Diagn Pathol; 2015 Sep; 32(5):352-61. PubMed ID: 25716099 [TBL] [Abstract][Full Text] [Related]
88. Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. Nowak JA; Yurgelun MB; Bruce JL; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; Agoston AT; Srivastava A; Ogino S; Kuo FC; Lindeman NI; Dong F J Mol Diagn; 2017 Jan; 19(1):84-91. PubMed ID: 27863258 [TBL] [Abstract][Full Text] [Related]
89. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas. Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990 [TBL] [Abstract][Full Text] [Related]
90. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas. Wang J; Li R; He Y; Yi Y; Wu H; Liang Z Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917 [TBL] [Abstract][Full Text] [Related]
91. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers. Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875 [TBL] [Abstract][Full Text] [Related]
92. Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parameters. Staffa L; Echterdiek F; Nelius N; Benner A; Werft W; Lahrmann B; Grabe N; Schneider M; Tariverdian M; von Knebel Doeberitz M; Bläker H; Kloor M PLoS One; 2015; 10(3):e0121980. PubMed ID: 25816162 [TBL] [Abstract][Full Text] [Related]
93. Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome. Huang M; Djordjevic B; Yates MS; Urbauer D; Sun C; Burzawa J; Daniels M; Westin SN; Broaddus R; Lu K Cancer; 2013 Aug; 119(16):3027-33. PubMed ID: 23760948 [TBL] [Abstract][Full Text] [Related]
94. High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum. Planck M; Rambech E; Möslein G; Müller W; Olsson H; Nilbert M Cancer; 2002 May; 94(9):2502-10. PubMed ID: 12015776 [TBL] [Abstract][Full Text] [Related]
95. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606 [TBL] [Abstract][Full Text] [Related]
96. Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome. Lamba AR; Moore AY; Moore T; Rhees J; Arnold MA; Boland CR Fam Cancer; 2015 Jun; 14(2):259-64. PubMed ID: 25637498 [TBL] [Abstract][Full Text] [Related]
97. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis. Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950 [TBL] [Abstract][Full Text] [Related]
98. Exclusive KRAS mutation in microsatellite-unstable human colorectal carcinomas with sequence alterations in the DNA mismatch repair gene, MLH1. Zhao Y; Miyashita K; Ando T; Kakeji Y; Yamanaka T; Taguchi K; Ushijima T; Oda S; Maehara Y Gene; 2008 Nov; 423(2):188-93. PubMed ID: 18692554 [TBL] [Abstract][Full Text] [Related]
99. Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process. Salvador MU; Truelson MRF; Mason C; Souders B; LaDuca H; Dougall B; Black MH; Fulk K; Profato J; Gutierrez S; Jasperson K; Tippin-Davis B; Lu HM; Gray P; Shah S; Chao EC; Ghahramani N; Landsverk M; Gau CL; Chen D; Pronold M J Clin Oncol; 2019 Mar; 37(8):647-657. PubMed ID: 30702970 [TBL] [Abstract][Full Text] [Related]
100. Genetic testing for hereditary nonpolyposis colorectal cancer. Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]